Search by Drug Name or NDC

    NDC 00597-0385-86 Trijardy XR 12.5; 2.5; 1000 mg/1; mg/1; mg/1 Details

    Trijardy XR 12.5; 2.5; 1000 mg/1; mg/1; mg/1

    Trijardy XR is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE.

    Product Information

    NDC 00597-0385
    Product ID 0597-0385_0cc7f716-30ec-497c-9aa0-4bfbf8b88d3e
    Associated GPIs 27996703407530
    GCN Sequence Number 080711
    GCN Sequence Number Description empaglifloz/linaglip/metformin TAB BP 24H 12.5-2.5MG ORAL
    HIC3 C4Y
    HIC3 Description ANTIHYPERGLY-SGLT-2 INHIB,DPP-4 INHIB,BIGUANIDE CB
    GCN 47671
    HICL Sequence Number 046321
    HICL Sequence Number Description EMPAGLIFLOZIN/LINAGLIPTIN/METFORMIN HCL
    Brand/Generic Brand
    Proprietary Name Trijardy XR
    Proprietary Name Suffix n/a
    Non-Proprietary Name empagliflozin, linagliptin, metformin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 12.5; 2.5; 1000
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
    Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
    Pharmaceutical Class Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212614
    Listing Certified Through 2024-12-31

    Package

    NDC 00597-0385-86 (00597038586)

    NDC Package Code 0597-0385-86
    Billing NDC 00597038586
    Package 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)
    Marketing Start Date 2020-04-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 9.16814
    Pricing Unit EA
    Effective Date 2022-01-10
    NDC Description TRIJARDY XR 12.5-2.5-1,000 MG
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 2
    Classification for Rate Setting B
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis